These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19578225)

  • 41. [The impact of immunization against measles on epidemiology of measles in Poland].
    Janaszek W
    Przegl Epidemiol; 1998; 52(4):413-25. PubMed ID: 10321085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The global burden of measles in the year 2000--a model that uses country-specific indicators.
    Stein CE; Birmingham M; Kurian M; Duclos P; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S8-14. PubMed ID: 12721886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progress in measles control--Zambia, 1999-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jun; 54(23):581-4. PubMed ID: 15959454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
    Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
    Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outbreak of measles in a highly vaccinated secondary school population.
    Sutcliffe PA; Rea E
    CMAJ; 1996 Nov; 155(10):1407-13. PubMed ID: 8943928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness and potential impact of rotavirus vaccination in the United States.
    Widdowson MA; Meltzer MI; Zhang X; Bresee JS; Parashar UD; Glass RI
    Pediatrics; 2007 Apr; 119(4):684-97. PubMed ID: 17403839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measles: not just another viral exanthem.
    Duke T; Mgone CS
    Lancet; 2003 Mar; 361(9359):763-73. PubMed ID: 12620751
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness of three different vaccination strategies against measles in Zambian children.
    Dayan GH; Cairns L; Sangrujee N; Mtonga A; Nguyen V; Strebel P
    Vaccine; 2004 Jan; 22(3-4):475-84. PubMed ID: 14670330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of supplementary immunization activities in measles-endemic areas: a case study from Guangxi, China.
    Zhuo J; Geng W; Hoekstra EJ; Zhong G; Liang X; Zhang J
    J Infect Dis; 2011 Jul; 204 Suppl 1():S455-62. PubMed ID: 21666199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness evaluation of measles immunization strategies on a college campus.
    Shlian DM; Matchar D; Seymann GB
    Fam Pract Res J; 1991 Jun; 11(2):193-207. PubMed ID: 1905455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measles vaccination response during Kosi floods, Bihar, India 2008.
    Varkey S; Krishna G; Pradhan N; Gupta SK; Caravotta J; Hombergh HV; Hoekstra E; Askari S; Kansal OP
    Indian Pediatr; 2009 Nov; 46(11):997-1002. PubMed ID: 19955583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Supplementary immunization activities (SIAs) in South Africa: comprehensive economic evaluation of an integrated child health delivery platform.
    Verguet S; Jassat W; Bertram MY; Tollman SM; Murray CJ; Jamison DT; Hofman KJ
    Glob Health Action; 2013 Mar; 6():1-9. PubMed ID: 23458088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness analysis of an intervention project engaging Traditional and Religious Leaders to improve uptake of childhood immunization in southern Nigeria.
    Oyo-Ita AE; Hanlon P; Nwankwo O; Bosch-Capblanch X; Arikpo D; Esu E; Auer C; Meremikwu M
    PLoS One; 2021; 16(9):e0257277. PubMed ID: 34529714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modeling the Cost of Vaccinating a Measles Zero-Dose Child in Zambia Using Three Vaccination Strategies.
    Mak J; Patenaude BN; Mutembo S; Pilewskie ME; Winter AK; Moss WJ; Carcelen AC
    Am J Trop Med Hyg; 2024 Jul; 111(1):121-128. PubMed ID: 38772386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Strategic planning for measles control: using data to inform optimal vaccination strategies.
    Simons E; Mort M; Dabbagh A; Strebel P; Wolfson L
    J Infect Dis; 2011 Jul; 204 Suppl 1():S28-34. PubMed ID: 21666174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau.
    Byberg S; Fisker AB; Thysen SM; Rodrigues A; Enemark U; Aaby P; Benn CS; Griffiths UK
    Glob Health Action; 2017; 10(1):1329968. PubMed ID: 28580855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
    Prosperi C; Thangaraj JWV; Hasan AZ; Kumar MS; Truelove S; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Cutts FT; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murhekar MV
    Vaccine; 2023 Jan; 41(2):486-495. PubMed ID: 36481106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Introduction of a second dose of measles in national immunization program in India: a major step towards eradication.
    Verma R; Khanna P; Bairwa M; Chawla S; Prinja S; Rajput M
    Hum Vaccin; 2011 Oct; 7(10):1109-11. PubMed ID: 22238787
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication program.
    Babigumira JB; Levin A; Burgess C; Garrison LP; Bauch CT; Braka F; Mbabazi WB; Nabyonga JO; Simons E; Dabbagh A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S116-23. PubMed ID: 21666152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.